Skip Navigation

Advertise|Press|Contact|FAQ|CWConnect

Bookmark/Print/Share

Home » Clinical Trials » Aspergillosis

Clinical Trial Details

Overview

Research Study Summary

A Phase 2/Phase 3 clinical study for patients with Allergic Bronchopulmonary Aspergillosis

Research Study Title

A Randomized Controlled Trial of Voriconazole in Allergic Bronchopulmonary Aspergillosis

Purpose

This is a research project to evaluate the efficacy and safety of two different treatment protocols in Allergic bronchopulmonary Aspergillosis.

To Learn more
Phase

2/3

Gender

Both Male and Female

Age

15 to 65 Years

Overall Status

Recruiting

Lead Sponsor

Postgraduate Institute of Medical Education and Research

Duration

24 Months

Facility Type

N/A

Eligibility

Both Male and Female ages 15 Years to 65 Years

Inclusion Criteria:

Presence of all the following three criteria:

  • Immediate cutaneous hyperreactivity on aspergillus skin test

  • Elevated total IgE levels > 1000 IU/mL

  • A fumigatus specific IgE levels > 0.35 kUA/L

And, two of the following criteria:

  • Presence of serum precipitating antibodies against A fumigatus

  • Fixed or transient radiographic pulmonary opacities

  • Total eosinophil count > 1000/µL

  • Central bronchiectasis on HRCT

Exclusion Criteria:

  • Failure to give informed consent

  • Intake of glucocorticoids for more than three weeks in the preceding six months

  • Enrollment in another trial of ABPA

  • Any exposure to azoles in the last six months

Site Locations (1)

Country State City Zip Facility and Contact
India Chandigarh 160012 Postgraduate Institute of Medical Education and Research

Ritesh Agarwal, MD, DM
Principal Investigator

Contact

Ritesh Agarwal, MD, DM
+911722756825
E-mail:

NCT ID: NCT01621321

Date Last Changed: May 13, 2013

DISCLAIMER: This site is run by CenterWatch, a publishing company that focuses on the clinical trials industry. The information provided in this service is designed to help patients find clinical trials that may be of interest to them, and to help patients contact the centers conducting the research. CenterWatch is neither promoting this research nor involved in conducting any of these trials. Some study summaries have been edited for clarity purposes to make them easier to understand. View more study details here.